Publication: Wednesday, April 21, 2021 3:07 PM
AstraZeneca vaccine should only be given to people over 60 years of age. No exception, regardless of the voluntary nature with which it is requested. According to the latest update of the vaccination strategy in Spain, ratified by the Public Health Commission, “there is still not enough information available” to leave the vaccination with the Anglo-Swedish antidote free. arbitrator.
In any case, as in previous strategy updates, it was never possible to choose a vaccine. In this, the health has been frank: “The choice of the vaccine (s) to be applied cannot be established by individual choices, but must be based on the effectiveness and indication of the vaccines to population groups.”
However, the case of AstraZeneca was different, as what was considered was that, given the possibility that not all doses are used, they can be used by the population (even if they are under the age of 60). But according to the strategy, for the moment “it does not seem appropriate” to authorize this voluntary vaccination either. According to the ministry, for not only ethical reasons – the main criterion by which the vaccine can not be chosen, to avoid inequalities – but mainly scientific.
“The proposal may not only contradict the ethical principles on which the strategy itself is based, but also, if there is still not enough information available to make the most appropriate decision, the value of informed consent. as a guarantee of an autonomous decision would be highly questionable. “In other words, according to Health, there is still no information, and without information there is no choice, since” the decision-making based on scientific evidence ”prevails above all.
There is still no decision on the second dose for those under 60
At the same time, the strategy’s own text recalls the safety and efficacy of the AstraZeneca vaccine, the benefits of which continue to be infinitely greater than the risks, for example in vulnerable groups: “Recently, a study carried out in people over 80 years of age has shown a substantial reduction in the risk of hospitalization from COVID-19. “And they’re collecting this research, precisely, because it was done with just one dose.
Precisely on this last point, health has not yet made a decision: what to do with people under the age of 60 who have received a dose of AstraZeneca, but who are still waiting for the second. In view of this, as the previous data shows, the executive emphasizes the effectiveness of the antidote even without supplementing the guideline. New studies are also underway, in particular to test the mixture of vaccines, the data of which are pending.
Read the full text of the sixth update of the COVID-19 vaccination strategy in Spain here: